/AREVF

AREVF Stock - AREV Life Sciences Global Corp.

Q: What is the analyst price target for AREVF?

Analyst price target information is not currently available for AREVF.

Q: What is AREVF's market cap?

Market capitalization information is not currently available for AREVF.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

SELL

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for AREVF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2018

FY2019

FY2020

FY2021

FY2022

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta5.55

52W High$0.01

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2022	FY2021	FY2020	FY2019	FY2018
Revenue	$49,113	$254,996	$190,577	$194,686	N/A
Gross Profit	$29,140	$185,117	$190,577	$129,126	$-52,469
Gross Margin	59.3%	72.6%	100.0%	66.3%	N/A
Operating Income	$-1,388,788	$-1,496,832	$-452,315	$-3,026,174	$-1,690,728
Net Income	$-1,444,106	$-990,311	$-1,048,878	$-3,192,836	$-8,426,815
Net Margin	-2940.4%	-388.4%	-550.4%	-1640.0%	N/A
EPS	$-0.05	$-0.04	$-0.07	$-0.36	$-1.47

Company Overview

AREV Life Sciences Global Corp., an integrated life science discovery company, produces and sells functional ingredients in Canada. The company's CBD-infused products, include Canna-Mulsion and NaturVax, anti- viral supplements; NaturRelax, a natural Sleep Aid; Natur Relief, an anti-inflator and pain relief product; and white label cannabis products, as well as a range of THC products, and cannabis skincare products and medicinal oils and edibles. Its ingredients are used in products that are targeted for sale in the natural health, medical, functional food, nutraceutical, sports nutrition, and bioceutical markets. In addition, the company's products address the areas of health, which include sleep deprivation, insomnia, anxiety, pain, and inflammatory conditions, as well as other specific ailments. Further, it offers nutraceutical product formulations under the Bare brand name; and ready-to-use therapeutic food products under the SUS-TAINN name. The company was formerly known as AREV NanoTec Brands Inc. and changed its name to AREV Life Sciences Global Corp. in August 2021. AREV Life Sciences Global Corp. was incorporated in 2005 and is based in Coquitlam, Canada.

Visit Website

Frequently Asked Questions about AREVF

What is AREVF's current stock price?

AREV Life Sciences Global Corp. (AREVF) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for AREVF?

No analyst price targets are currently available for this stock.

What sector is AREV Life Sciences Global Corp. in?

AREV Life Sciences Global Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is AREVF's market cap?

AREV Life Sciences Global Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does AREVF pay dividends?

No, AREV Life Sciences Global Corp. does not currently pay a dividend to shareholders.